SheMed Built a $1 Billion Business on GLP-1s. Its Next Bet Goes Beyond Weight Loss

SheMed’s study of more than 8,000 women found improvements in weight, blood sugar, and cholesterol. Its founders believe that’s just the start of what GLP-1 research could uncover.

Oct 27, 2026 - 15:00
 0  3
SheMed Built a $1 Billion Business on GLP-1s. Its Next Bet Goes Beyond Weight Loss
SheMed’s study of more than 8,000 women found improvements in weight, blood sugar, and cholesterol. Its founders believe that’s just the start of what GLP-1 research could uncover.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow